Cash Flow from Operating Activities: A company's cash flows from operations.
Petros Pharmaceuticals, Inc. (PTPI) had Cash Flow from Operating Activities of $-5.80M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.15M |
|
-- |
|
-- |
|
$0.99M |
|
$-0.99M |
|
$0.07M |
|
$-0.92M |
|
$-0.92M |
|
$-0.92M |
|
$-0.92M |
|
$-0.92M |
|
$-0.92M |
|
$-0.99M |
|
$-0.99M |
|
42.28M |
|
42.28M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$6.13M |
|
-- |
|
-- |
|
$6.13M |
|
$2.77M |
|
-- |
|
-- |
|
$2.77M |
|
$3.37M |
|
$3.37M |
|
$3.37M |
|
42.28M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-5.80M |
-- |
|
$8.16M |
|
$3.71M |
|
$6.07M |
|
$2.36M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.40% |
|
-27.40% |
|
-15.04% |
|
-27.40% |
|
$0.08 |
|
$-0.14 |
|
$-0.14 |
|